Nuno Tiago Tavares

Mr. Nuno Tiago Tavares

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Inês Alexandra MarquesInês Alexandra Marques
Inês Alexandra Marques
CFCarolina Fernandes
Carolina Fernandes
NTNuno Tiago Tavares
Nuno Tiago Tavares
Ana Salomé PiresAna Salomé Pires
Ana Salomé Pires
Ana Margarida AbrantesAna Margarida Abrantes
Ana Margarida Abrantes
Maria Filomena BotelhoMaria Filomena Botelho
Maria Filomena Botelho
Cell-based assays, conducted on monolayer (2D) cultured cells, are an unquestionably valuable tool for biomedical research. However, three-dimensional (3D) cell culture models have gained relevance over the last few years due to the advantages of better mimicking the microenvironment and tissue microarchitecture in vivo. Recent magnetic-based 3D (m3D) cell culture systems can be used for this purpose. These systems are based on exposing magnetized cells to magnetic fields by levitation, bioprinting, or ring formation to promote cell aggregation into 3D structures. However, the successful development of these structures is dependent on several methodological characteristics and can be applied to mimic different human tissues. Thus, a systematic review was performed using Medline (via Pubmed), Scopus, and Web of Science (until February 2022) databases to aggregate studies using m3D culture in which human tissues were mimicked. The search generated 3784 records, of which 25 met the inclusion criteria. The usability of these m3D systems for the development of homotypic or heterotypic spheroids with or without scaffolds was explored in these studies. We also explore methodological differences specifically related to the magnetic method. Generally, the development of m3D cultures has been increasing, with bioprinting and levitation systems being the most used to generate homotypic or heterotypic cultures, mainly to mimic the physiology of human tissues, but also to perform therapeutic screening. This systematic review showed that there are areas of research where the application of this method remains barely explored, such as cancer research.

21 August 2022 in Andrology
Verified
Journal Article
Closed access
VCVera Constâncio
Vera Constâncio
NTNuno Tiago Tavares
Nuno Tiago Tavares
Rui HenriqueRui Henrique
Rui Henrique
Carmen JeronimoCarmen Jeronimo
Carmen Jeronimo
João LoboJoão Lobo
João Lobo

13 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
NTNuno Tiago Tavares
Nuno Tiago Tavares
Saulė GumauskaitėSaulė Gumauskaitė
Saulė Gumauskaitė
João LoboJoão Lobo
João Lobo
Carmen JeronimoCarmen Jeronimo
Carmen Jeronimo
Rui HenriqueRui Henrique
Rui Henrique
Platinum-based chemotherapy is routinely used for the treatment of several cancers. Despite all the advances made in cancer research regarding this therapy and its mechanisms of action, tumor resistance remains a major concern, limiting its effectiveness. DNA methylation-based biomarkers may assist in the selection of patients that may benefit (or not) from this type of treatment and provide new targets to circumvent platinum chemoresistance, namely, through demethylating agents. We performed a systematic search of studies on biomarkers that might be predictive of platinum-based chemotherapy resistance, including in vitro and in vivo pre-clinical models and clinical studies using patient samples. DNA methylation biomarkers predictive of response to platinum remain mostly unexplored but seem promising in assisting clinicians in the generation of more personalized follow-up and treatment strategies. Improved methodologies for their detection and quantification, including non-invasively in liquid biopsies, are additional attractive features that can bring these biomarkers into clinical practice, fostering precision medicine.

28 March 2025 in The Journal of Pathology
Verified
Journal Article
Open access
João LoboJoão Lobo
João Lobo
NTNuno Tiago Tavares
Nuno Tiago Tavares
DFDiana Fonseca
Diana Fonseca
Carmen JeronimoCarmen Jeronimo
Carmen Jeronimo
Rui HenriqueRui Henrique
Rui Henrique
AAAndres Martin Acosta
Andres Martin Acosta
Somatic‐type malignancies (SMs) arising in germ cell tumors (GCTs) are aggressive neoplasms resistant to systemic treatment. Most are diagnosed in metastatic sites after chemotherapy; however, they have also been well‐documented in primary testicular GCTs. Historically, SMs were thought to originate in components of teratoma that acquire molecular alterations equivalent to those that characterize their true somatic counterparts. However, recent studies have shown that SMs typically lack the hallmark molecular alterations seen in similar somatic tumors. Additionally, clinicopathologic and molecular data suggest that a subset may derive from yolk sac tumor (YST) rather than teratoma. In this study, we evaluated the relationship between conventional histological types of GCTs and SMs by comparing expression of microRNA (miR)‐371–373 and genomic methylation profiles. A total of 96 samples (including multiple paired conventional GCT–SM samples from individual tumors) were assessed for miR‐371–373 expression by RT‐qPCR and genomic DNA methylation using a clinically validated assay. Expression of miR‐371–373 was higher in conventional GCTs than in SMs (considered as a single category encompassing all histological subtypes). However, miR‐371–373 expression was heterogeneous among SMs, with significantly higher levels in sarcomatoid YST (SYST) and glandular neoplasms than in other SMs. Genomic DNA methylation analysis showed that SMs (considered as a single category) did not form a distinct cluster. Instead, they grouped into multiple clusters that did not show perfect correspondence with histology and often included conventional GCTs. Genome‐wide methylation assessment showed a higher abundance of hypermethylated regions in SMs than in conventional GCTs. Analysis of paired conventional GCT and ‘somatic‐type’ components that did not meet size criteria for SMs dissected from individual tumors demonstrated separation according to histology, suggesting that epigenetic processes play a role in the transition from conventional GCT to ‘somatic‐type’ phenotypes. Gene‐level and pathway‐level analyses identified MAPK/RAS signaling, mitosis/proliferation, differentiation towards neural tissue/neuroectoderm, epithelial‐to‐mesenchymal transition, and DNA repair as key differentially regulated processes in components with somatic‐type histology, suggesting mechanisms of progression from conventional to ‘somatic’ phenotypes in GCT. These results support the hypothesis that a subset of SMs derive from YST and suggest that some subtypes (such as SYST) may represent ‘intermediate’ phenotypes. Additionally, analysis of differentially methylated promoter regions in SM identified genes and biologic processess that may underlie 'somatic tranformation' in GCTs. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

25 April 2023 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
NTNuno Tiago Tavares
Nuno Tiago Tavares
Rui HenriqueRui Henrique
Rui Henrique
ABAditya Bagrodia
Aditya Bagrodia
Carmen JeronimoCarmen Jeronimo
Carmen Jeronimo
João LoboJoão Lobo
João Lobo
Testicular germ cell tumors (TGCT) are the most commonly diagnosed cancers among young men. Although these tumors usually have a good prognosis and are highly treatable, clinicians and pathologists...

26 April 2023 in Histopathology
Verified
Journal Article
Closed access
João LoboJoão Lobo
João Lobo
NTNuno Tiago Tavares
Nuno Tiago Tavares
DSDaniela Barros Silva
Daniela Barros Silva
ARAlina Rosinha
Alina Rosinha
AMAntónio Morais
António Morais
Rui HenriqueRui Henrique
Rui Henrique